BRIEF published on 01/07/2026 at 19:17, 9 months 9 days ago Bilan semestriel du contrat de liquidité d'ABIONYX Pharma Contrat De Liquidité TP ICAP Europe Transactions Boursières ABIONYX Pharma Actions Et Espèces
BRIEF published on 01/07/2026 at 19:17, 9 months 9 days ago ABIONYX Pharma's Half-Yearly Review of Liquidity Contract Liquidity Contract TP ICAP Europe Stock Market Transactions ABIONYX Pharma Stocks And Cash
PRESS RELEASE published on 01/07/2026 at 19:12, 9 months 9 days ago Inside Information / Other news releases ABIONYX Pharma releases half-yearly report on liquidity contract with TP ICAP (Europe) SA, detailing shares and cash balance for 2025 Liquidity Contract Shares TP ICAP Cash Balance ABIONYX Pharma
PRESS RELEASE published on 01/07/2026 at 19:12, 9 months 9 days ago Informations privilégiées / Autres communiqués Bilan semestriel du contrat de liquidité d'ABIONYX Pharma avec TP ICAP (Europe) SA : achat de 437 203 titres pour 1 389 323,53€ et vente de 536 477 titres pour 1 560 333,66€ Contrat De Liquidité TP ICAP Achat Vente ABIONYX Pharma
BRIEF published on 12/16/2025 at 21:23, 10 months ago ABIONYX Pharma Announces a Capital Increase Fundraising Capital Increase Biopharmaceutical ABIONYX Pharma Sepsis
BRIEF published on 12/16/2025 at 21:23, 10 months ago ABIONYX Pharma Announces €1.8 Million Capital Increase Capital Increase Subscription Rights Euronext Listing ABIONYX Pharma Financial Visibility
BRIEF published on 12/16/2025 at 21:23, 10 months ago ABIONYX Pharma Annonce une Augmentation de Capital Augmentation De Capital Biopharmaceutique Levée De Fonds ABIONYX Pharma Sepsis
BRIEF published on 12/16/2025 at 21:23, 10 months ago ABIONYX Pharma annonce une augmentation de capital de 1,8 million d'euros. Augmentation De Capital Cotation Euronext Visibilité Financière ABIONYX Pharma Droits D'abonnement
PRESS RELEASE published on 12/16/2025 at 21:18, 10 months ago Inside Information / Other news releases ABIONYX Pharma launches €1.8m capital increase with removal of preferential subscription rights, subscription price at 3.10 euros for new shares, extending financial visibility until 2026 Capital Increase Biopharma Preferential Subscription Rights ABIONYX Pharma Financial Visibility
PRESS RELEASE published on 12/16/2025 at 21:18, 10 months ago Informations privilégiées / Autres communiqués ABIONYX Pharma lance une augmentation de capital de 1,8M€ avec suppression du droit préférentiel de souscription à 3,10 euros par action et extension de la visibilité jusqu'à fin 2026 Augmentation De Capital Droit Préférentiel De Souscription ABIONYX Pharma Visibilité 3,10 Euros
Published on 10/17/2026 at 03:20, 14 hours 31 minutes ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 14 hours 36 minutes ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 18 hours 16 minutes ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 18 hours 21 minutes ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 18 hours 51 minutes ago Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update
Published on 10/17/2026 at 13:05, 4 hours 46 minutes ago Luong Quoi Coconut Vietnam to Showcase Vietnamese Coconut Expertise at SIAL Paris 2026
Published on 10/17/2026 at 12:50, 5 hours 1 minute ago AGFUND wins international award for excellence in inclusive banking and social impact
Published on 10/16/2026 at 20:08, 21 hours 43 minutes ago EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 22 hours 31 minutes ago Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation
Published on 10/16/2026 at 19:05, 22 hours 46 minutes ago Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers
Published on 10/16/2026 at 19:54, 21 hours 57 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 septembre 2026
Published on 10/16/2026 at 18:48, 23 hours 3 minutes ago Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 18:48, 23 hours 3 minutes ago Déclaration hebdomadaire d'opérations effectuées du 12 au 16 octobre 2026
Published on 10/16/2026 at 18:00, 23 hours 51 minutes ago KLARSEN : Compte rendu AGO et AGE du 8 octobre 2026
